3189 results for «686»

Filter By

3189 results

Challenging STEMI scenarios - Part 1

11 Dec 2025 – From GulfPCR-GIM 2025

This session addresses challenging STEMI scenarios with a focus on atypical presentations, complex complications, and advanced management strategies. Through diverse case discussions, it highlights approaches to overcome procedural difficulties, manage large thrombus burdens, and avoid clinical pitfalls in acute STEMI care.

Challenging STEMI scenarios - Part 1

Calcified lesions: LIVE Educational Case from King Faisal Cardiac Center, National Guard Health Affairs- Western region - Jeddah, Saudi Arabia

11 Dec 2025 – From GulfPCR-GIM 2025

This educational session from King Faisal Cardiac Center provides a detailed examination of optimal device use in calcified coronary lesions, emphasizing the role of intracoronary imaging to improve PCI results and patient outcomes. It also offers guidance on selecting appropriate strategies for coronary bifurcation lesions through...

Calcified lesions: LIVE Educational Case from King Faisal Cardiac Center, National Guard Health Affairs- Western region - Jeddah, Saudi Arabia

Innovation and teamwork in structural heart interventions

11 Dec 2025 – From GulfPCR-GIM 2025

This session explores innovations and collaborative approaches in structural heart interventions, focusing on aortic and mitral valve procedures. It addresses procedural indications, challenges, and the evolving roles of non-physician allied professionals. Interactive elements foster knowledge exchange and support the growth of expertise in the structural heart...

Innovation and teamwork in structural heart interventions

Challenging STEMI scenarios - Part 2

11 Dec 2025 – From GulfPCR-GIM 2025

This session presents complex STEMI cases that highlight the challenges of acute coronary syndrome management, including difficult arterial access, balancing reperfusion with embolization risks, and rare complications such as spontaneous coronary artery dissections. It emphasizes nuanced decision-making in high-stakes clinical scenarios.

Challenging STEMI scenarios - Part 2

NIRS-guided PCI: beyond calcium to precision PCI

11 Dec 2025 – From GulfPCR-GIM 2025

This session explores how near-infrared spectroscopy (NIRS) is redefining PCI by revealing what angiography cannot see. By identifying lipid-rich and vulnerable plaques, NIRS helps anticipate procedural risk and refine decision-making before stent implantation. The session shows how plaque composition, rather than calcium alone, can guide lesion...

NIRS-guided PCI: beyond calcium to precision PCI

PCR Tokyo Valves 2026 Closing Ceremony

15 Feb 2026 – From PCR Tokyo Valves 2026

The Closing Ceremony marks the conclusion of this cardiology conference, providing a formal wrap-up and reflection on the key highlights and advancements presented throughout the event. It serves as an opportunity to acknowledge contributors and set the stage for future initiatives in interventional cardiology.

PCR Tokyo Valves 2026 Closing Ceremony

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial

26 Aug 2023

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Nicola Ryan

Author

Nicola Ryan
BIOFLOW DAPT - Biodegradable polymer SES vs durable polymer ZES in HBR subjects with 1-month DAPT
Didn’t find what you were looking for?